Ross Lamb had no idea that Angelina Jolie’s double mastectomy could have anything to do with his prostate cancer. Until he ...

Diseases like cancer or neurodegeneration are known to arise from genetic misfires. But treating such complex conditions hasn ...

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...

An international group have discovered associations between pathogenic variants of the BRCA 1 and 2 genes and four types of ...

Researchers have found a link between healthier diets containing fruits, vegetables, and whole grains and higher rates of ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

In this episode of Community Corner, Christopher H. Lieu, MD, professor of medicine at the University of Colorado Cancer ...

At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health ...

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.